rs2070188

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002778.4(PSAP):​c.-4C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.145 in 1,550,292 control chromosomes in the GnomAD database, including 17,527 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1170 hom., cov: 34)
Exomes 𝑓: 0.15 ( 16357 hom. )

Consequence

PSAP
NM_002778.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.743

Publications

25 publications found
Variant links:
Genes affected
PSAP (HGNC:9498): (prosaposin) This gene encodes a highly conserved preproprotein that is proteolytically processed to generate four main cleavage products including saposins A, B, C, and D. Each domain of the precursor protein is approximately 80 amino acid residues long with nearly identical placement of cysteine residues and glycosylation sites. Saposins A-D localize primarily to the lysosomal compartment where they facilitate the catabolism of glycosphingolipids with short oligosaccharide groups. The precursor protein exists both as a secretory protein and as an integral membrane protein and has neurotrophic activities. Mutations in this gene have been associated with Gaucher disease and metachromatic leukodystrophy. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
PSAP Gene-Disease associations (from GenCC):
  • combined PSAP deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
  • Gaucher disease due to saposin C deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • Krabbe disease due to saposin A deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • metachromatic leukodystrophy due to saposin B deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • Parkinson disease 24, autosomal dominant, susceptibility to
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 10-71851225-G-A is Benign according to our data. Variant chr10-71851225-G-A is described in CliVar as Benign. Clinvar id is 258806.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.244 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSAPNM_002778.4 linkc.-4C>T 5_prime_UTR_variant Exon 1 of 14 ENST00000394936.8 NP_002769.1 P07602-1A0A024QZQ2
PSAPNM_001042465.3 linkc.-4C>T 5_prime_UTR_variant Exon 1 of 15 NP_001035930.1 P07602-3
PSAPNM_001042466.3 linkc.-4C>T 5_prime_UTR_variant Exon 1 of 15 NP_001035931.1 P07602-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSAPENST00000394936.8 linkc.-4C>T 5_prime_UTR_variant Exon 1 of 14 1 NM_002778.4 ENSP00000378394.3 P07602-1

Frequencies

GnomAD3 genomes
AF:
0.117
AC:
17768
AN:
152188
Hom.:
1167
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0569
Gnomad AMI
AF:
0.143
Gnomad AMR
AF:
0.0889
Gnomad ASJ
AF:
0.113
Gnomad EAS
AF:
0.256
Gnomad SAS
AF:
0.103
Gnomad FIN
AF:
0.116
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.150
Gnomad OTH
AF:
0.120
GnomAD2 exomes
AF:
0.128
AC:
19787
AN:
154448
AF XY:
0.129
show subpopulations
Gnomad AFR exome
AF:
0.0570
Gnomad AMR exome
AF:
0.0668
Gnomad ASJ exome
AF:
0.103
Gnomad EAS exome
AF:
0.248
Gnomad FIN exome
AF:
0.114
Gnomad NFE exome
AF:
0.156
Gnomad OTH exome
AF:
0.126
GnomAD4 exome
AF:
0.149
AC:
207747
AN:
1397984
Hom.:
16357
Cov.:
32
AF XY:
0.147
AC XY:
101679
AN XY:
689596
show subpopulations
African (AFR)
AF:
0.0541
AC:
1710
AN:
31582
American (AMR)
AF:
0.0676
AC:
2412
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
2586
AN:
25170
East Asian (EAS)
AF:
0.296
AC:
10560
AN:
35724
South Asian (SAS)
AF:
0.110
AC:
8709
AN:
79214
European-Finnish (FIN)
AF:
0.117
AC:
5683
AN:
48728
Middle Eastern (MID)
AF:
0.132
AC:
750
AN:
5698
European-Non Finnish (NFE)
AF:
0.155
AC:
167195
AN:
1078204
Other (OTH)
AF:
0.140
AC:
8142
AN:
57964
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
9228
18456
27683
36911
46139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6040
12080
18120
24160
30200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.117
AC:
17764
AN:
152308
Hom.:
1170
Cov.:
34
AF XY:
0.116
AC XY:
8637
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0569
AC:
2365
AN:
41580
American (AMR)
AF:
0.0888
AC:
1360
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.113
AC:
391
AN:
3470
East Asian (EAS)
AF:
0.256
AC:
1321
AN:
5168
South Asian (SAS)
AF:
0.102
AC:
495
AN:
4830
European-Finnish (FIN)
AF:
0.116
AC:
1232
AN:
10618
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.150
AC:
10186
AN:
68008
Other (OTH)
AF:
0.119
AC:
251
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
827
1654
2482
3309
4136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.132
Hom.:
1899
Bravo
AF:
0.111
Asia WGS
AF:
0.127
AC:
443
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 22, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Combined PSAP deficiency Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Krabbe disease due to saposin A deficiency Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sphingolipid activator protein 1 deficiency Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gaucher disease due to saposin C deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Metachromatic leukodystrophy Benign:1
Nov 20, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
11
DANN
Benign
0.70
PhyloP100
0.74
PromoterAI
-0.13
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2070188; hg19: chr10-73610982; COSMIC: COSV67550446; API